Chronic Kidney Disease

Risk of acute kidney injury was greater in patients with preexisting chronic kidney disease than those without after two-stage exchange arthroplasty with a high-dose antibiotic-loaded bone cement spacer, according to results.

Patients aged 75 years and older with chronic kidney disease, type 2 diabetes, hypertension and hyperkalemia had “significant reductions in serum potassium” after treatment with patiromer, according to results of a secondary analysis.

Monogram Health, a company focused on providing management services for patients with kidney disease, has expanded access to its in-home kidney care management program, allowing for more Cigna Medicare Advantage members to join it.

For patients with advanced chronic kidney disease, low serum zinc concentration was linked to an increased likelihood of hospitalizations due to infections. This elevated risk was especially high for individuals on proton pump inhibitors.

Kidney Disease: Improving Global Outcomes has revised its guideline on managing blood pressure in patients with chronic kidney disease. The guideline was originally published in 2012.

Researchers from Canada found placement of an arteriovenous fistula slowed decline in kidney function for patients with advanced chronic kidney disease who were not yet on hemodialysis.

Nocturnal systolic hypertension conferred a higher likelihood of adverse kidney and cardiovascular outcomes in patients with chronic kidney disease, according to a study that compared different nocturnal hypertension entities.

Higher physical activity levels were associated with a 52% lower mortality rate vs. lower levels of activity, according to a study that assessed the link between activity and health outcomes for patients with chronic kidney disease.

For patients with chronic kidney disease, higher doses of the muscle relaxant baclofen appeared to increase risk for hospitalization due to fall or hypotension, with primary care physicians being most likely to prescribe the medication.

The National Kidney Foundation has launched a clinical tool that assesses chronic kidney disease in pediatric patients, thereby allowing for improved predictions of disease progression.